AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study NCT06007352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gentamicin
Description: Participants will be given 120 mg of gentamicin infused in 3 L NaCl used in irrigation for ureteroscopy
Study NCT06007352 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3 L of NaCl irrigation typically used for ureteroscopy surgery
Study NCT04617522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab Govitecan-hziy
Description: Administered intravenously
Study NCT04466527 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser Intervention
Description: Subjects with undergo laser exposure of their active acne vulgaris.
Study NCT04762277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spesolimab - solution for infusion
Description: Solution for infusion
Study NCT04762277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching spesolimab - solution for infusion
Description: Solution for infusion
Study NCT04762277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spesolimab- solution for injection
Description: Solution for injection
Study NCT04762277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching to spesolimab- solution for injection
Description: Solution for injection
Study NCT05897710 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual World-Based Cardiac Rehabilitation (VWCR)
Description: 12-week virtual world technology-based program via Second Life platform. Weekly virtual visits with nurse coach and exercise physiologist, weekly education sessions, and social support group discussions within the virtual world environment.
Study NCT05897710 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Center-Based Cardiac Rehabilitation (CBCR)
Description: Traditional 12-week in-person cardiac rehabilitation program; standard of care at participant's cardiac rehabilitation facility
Study NCT04896736 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care in this study means the standard perioperative care. Patients who are meant to receive usual care will receive both cerebral and muscular tissue oxygen saturation monitoring; however, the monitor screen will be covered and the monitoring data will not be used to guide clinical care.
Study NCT01085721 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexchlorpheniramine, pseudoephedrine, guaifenesin
Description: 5 mL (2 mg dexchlorpheniramine, 20 mg pseudoephedrine and 100 mg guaifenesin) qid for 5 days
Study NCT01085721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexchlorpheniramine
Description: 5 mL (2 mg dexchlorpheniramine) qid for 5 days
Study NCT05290727 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Aquoral Lipo (Esteve)
Description: 15-day randomized treatment period of each of the clinical trial products (experimental and control) with a 1-week washout period prior to use of the study products
Study NCT05290727 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Hyabak (Thea)
Description: 15-day randomized treatment period of each of the clinical trial products (experimental and control) with a 1-week washout period prior to use of the study products
Study NCT05875311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: telemonitoring
Description: The system consists of the following elements:~Professional website at the ambulatory centre, which allows:~To set up an individualised care plan To establish the patient's risk profile and targets for improvement. Long-term monitoring of the evolution of cardiovascular risk factors and events that occurred Advise the patient on self-management strategies.~Mobile application software with the following functions:~Scheduled exercise sessions Medication reminder Measurement reminder (weight, blood pressure, heart rate, waist circumference, etc.) Messages: Inbox folder for system messages and messages generated by professionals for a specific patient or video conference.~Training monitor: guides the patient in the performance of their exercise. Access to certified health information for patients
Study NCT05875311 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: control follow-up
Description: Patients are instructed to perform 150 minutes per week of moderate physical activity and follow healthy lifestyles
Study NCT05676346 — intervention group
Intervention type: GENETIC
Intervention: LUTS
Description: Patients included in this group are subjects with lower urinary tracto symptoms. An oral mucosa swab will be used to extract a genetic specimen
Study NCT05484661 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BCAA
Description: Participants will participate in high-volume, moderate-intensity exercise 3x/week and consume either a placebo or BCAA (\~7-10 g of BCAAs (100 mg/kg) daily for eight weeks.
Study NCT05484661 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: BCAA
Description: Participants will participate in high-volume, moderate-intensity exercise 3x/week and consume either a placebo or BCAA (\~7-10 g of BCAAs (100 mg/kg) daily for eight weeks.
Study NCT05858853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Serum Albumin
Description: The experimental drug (recombinant human serum albumin injection) was administered 10 g/ day for 14 days
Study NCT05858853 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Serum Albumin
Description: The experimental drug (recombinant human serum albumin injection) was administered 20 g/ day for 7 days
Study NCT05858853 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human serum albumin
Description: Control drug (human blood albumin injection) 10 g/ day for 14 days
Study NCT05497804 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Given SC
Study NCT05497804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given IV/PO
Study NCT04149119 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Attractive Target Sugar Baits (ATSB)
Description: Within the intervention area, a total of four ATSB station will be deployed (external wall). ATSB stations will be monitored by community health workers through weekly visit and all stations will be replaced 6months after deployment.
Study NCT06440226 — intervention group
Intervention type: BEHAVIORAL
Intervention: Eye Movement Technique
Description: Participants were instructed to move their eyes as much as possible with their eyes closed just before falling asleep. This technique aimed to mimic the Rapid Eye Movement (REM) sleep phase, which is often associated with more vivid and memorable dreams.
Study NCT06440226 — intervention group
Intervention type: BEHAVIORAL
Intervention: Memory Recall of Previous Night's Thoughts
Description: Another intervention involved asking participants to recall and think about their thoughts or events from the previous night before going to sleep. This method engaged cognitive processes related to memory and reflection, potentially setting the stage for increased awareness during sleep.
Study NCT06440226 — intervention group
Intervention type: BEHAVIORAL
Intervention: Recall of Previous Lucid Dreams
Description: Participants were also asked to recall their lucid dreams from previous nights. This intervention seemed to activate memory and awareness related to dreaming, which significantly increased the likelihood of experiencing lucid dreams the following night.
Study NCT05497804 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA scan
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT05497804 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chest Radiography
Description: Undergo chest x-ray
Study NCT06581198 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rapcabtagene autoleucel Regimen 1
Description: single infusion of rapcabtagene autoleucel
Study NCT06581198 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rapcabtagene autoleucel Regimen 2
Description: single infusion of rapcabtagene autoleucel
Study NCT06581198 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: The treatment regimen must be in line with KDIGO guidelines for treatment of class III/IV LN.
Study NCT06063499 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program for Addictions
Description: The Healthy Minds Program for Addictions is a 6-week, hybrid version of the original Healthy Minds Program (HMP), in which all lessons are adapted from the original lessons available in the app and delivered exclusively in person over weekly group sessions. The HMP has >100 guided audio practices that address 4 constituents of wellbeing: awareness, connection, insight, and purpose. Study participants will have access to specific practices from the HMP that are particularly relevant to the needs of populations with substance use disorders and trauma.
Study NCT04903470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bisacodyl
Description: Biscodyl a stimulant laxative is expected to stimulate rectal contraction and enhance expulsion of Fecobionics
Study NCT04903470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropin
Description: Atropin is an anticholinergic drug that is expected to inhibit rectal contractions and make defecation more difficult.
Study NCT05490290 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active
Description: In the active intervention condition, decision support is provided during the referral procedure of medical imaging exams.
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Oxidant Unflavored Little Cigar - Group A
Description: Subjects will be provided with high oxidant unflavored little cigars (One to take home and use ad lib and upon return to the lab, subjects will be given an additional high oxidant unflavored little cigar to use for outcome measure data collection in the lab)
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Oxidant Unflavored Little Cigar - Group B
Description: Subjects will be provided with low oxidant unflavored little cigars (One to take home and use ad lib and upon return to the lab, subjects will be given an additional low oxidant unflavored little cigar to use for outcome measure data collection in the lab)
Study NCT05858853 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human serum albumin
Description: Control drug (human blood albumin injection) 20 g/ day for 7 days
Study NCT05850910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supine practice group
Description: The practitioner's arm was placed in the mid-thoracic region from the opposite side of the individual's torso in the form of a half fist. In this position, the SPs coincide with the space in the middle of the half fist, while the TPs coincide with the fingertips and the thenar region. With the practitioner's other hand supporting the patient's elbows, a high-speed-low-amplitude thrust is applied from front to back.
Study NCT05850910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prone application group
Description: the practitioner positions the hypothenar part of his hands above the TPs in the mid-thoracic segment. From this point, a high-velocity-low-amplitude thrust is applied from the back to the front.
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Oxidant Flavored Little Cigar - Group C
Description: Subjects will be provided with high oxidant flavored little cigars (One to take home and use ad lib and upon return to the lab, subjects will be given an additional high oxidant flavored little cigar to use for outcome measure data collection in the lab)
Study NCT06168630 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual lymph drainage
Description: It consists of patients who will receive manual lymph drainage everyday for 5 days. The subject's position will be supine with their knees bent. Every session will be of 45 minutes. Manual lymph drainage will with abdominal lymph drainage, after which central lymph stimulation will be performed. Then, by stimulating the bilateral axillary lymph nodes, the flow of fluid over the right and left breasts will be directed toward the axillary lymph nodes. While the patients in the prone position, bilateral axillary lymph nodes will be stimulated, and each manual lymph drainage will be performed from the dorsum to the axillary lymph node .
Study NCT06168630 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: The other group will receive massage for 20 minutes every day for 5 days from first day of treatment. Massage will be done using the index and middle fingers in a spiral motion towards the nipples.
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Oxidant Flavored Little Cigar - Group D
Description: Subjects will be provided with low oxidant flavored little cigars (One to take home and use ad lib and upon return to the lab, subjects will be given an additional low oxidant flavored little cigar to use for outcome measure data collection in the lab)
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Cigarette - Group E
Description: Subjects will use one of their own cigarettes in the collection of outcome measure data in the lab.
Study NCT06310187 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Unlit Little Cigar - Group F
Description: Subjects will be provided with an unlit little cigars to use for outcome measure data collection in the lab. This will be the control group for outcome measure data.
Study NCT06163430 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TERN-701
Description: TERN-701 orally QD
Study NCT05053867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tranexamic acid
Description: Inhaled
Study NCT05053867 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Standard of Care
Study NCT06541210 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT06127199 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ovaprene
Description: Non-hormonal intravaginal ring
Study NCT04310020 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV
Study NCT04310020 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04310020 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT04752150 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Analgesia management; group ESPB and RIB
Description: Patients will be administered ibuprofen 400 mgr IV every 8 hours in the postoperative period. A patient controlled device prepared with 10 mcg/ ml fentanyl will be attached to all patients with a protocol included 10 mcg bolus without infusion dose, 10 min lockout time and 4 hour limit. Postoperative patient evaluation will be performed by an anesthesiologist blinded to the procedure.
Study NCT04310020 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiation Therapy
Description: Undergo hypofractionated radiation therapy
Study NCT04310020 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05828810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidne Gluconate-Alcohol Skin Preparation
Description: Participants will undergo skin antisepsis with 4% chlorhexidine gluconate pre-wash, followed by 2% chlorhexidine gluconate with 70% isopropyl alcohol skin preparation.~The surgical field to be sterilized will be at the discretion of the surgical team, but typically includes the distal torso to ankle for patients undergoing hip arthroplasty and proximal thigh to ankle for patients undergoing knee arthroplasty.~Pre-wash of the surgical area will be carried out using a wet chlorhexidine surgical scrub brush followed by immediate drying using towels. The definitive preparation will then be carried out using tinted chlorhexidine gluconate-alcohol sponges applied with forceps. The drying time and the minimum number of sponge packs used will comply with the product 'Instructions for Use'. The drapes can be applied as per the surgeon's usual approach and they will be treated according to the institution and surgeon's routine practice for draping and surgical site infection prevention.
Study NCT05828810 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Poviodine-iodine Skin Preparation
Description: Participants will undergo skin antisepsis with 7.5% povidone-iodine detergent pre-wash, followed by 10% povidone-iodine skin preparation.~The surgical field to be sterilized will be at the discretion of the surgical team, but typically includes the distal torso to ankle for patients undergoing hip arthroplasty and proximal thigh to ankle for patients undergoing knee arthroplasty.~Pre-wash of the surgical area will be carried out using iodine detergent soaked gauze pads followed by immediate drying using towels. The definitive preparation will then be carried out using povidone-iodine soaked gauze pads applied with forceps. The drapes can be applied as per the surgical team's usual approach and they otherwise will be treated according to the institution and surgeon's routine practice for draping and surgical site infection prevention.
Study NCT05856591 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Food Resources & Kitchen Skills (FoRKS)
Description: Food Resources \& Kitchen Skills (FoRKS) includes 5 weeks of hypertension classes followed by 11 weeks of home-delivered Mediterranean-style ingredient kits and virtual cooking classes with embedded lessons in kitchen organization, tool use, nutrition, budgeting, and shopping.
Study NCT05856591 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Description: Enhanced Usual Care (EUC) includes 5 weeks of hypertension classes.
Study NCT06096038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: cyclophosphamide 300 mg/meter square IV
Study NCT06096038 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: fludarabine 30 mg/meter square IV × 3 days
Study NCT06096038 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cell Therapy
Description: the autologous T lymphocyte chimeric antigen receptor cells against the CSPG4 antigen iC9-CAR.CSPG4 T cell infusion iC9-CAR.CSPG4 T cell infusion
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RMC-6291
Description: Oral tablet
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RMC-6236
Description: Oral tablet
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV Infusion
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV Infusion
Study NCT06043089 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot juice supplementation or placebo
Description: Athletes received 7 days of beetroot juice supplementation with nitrate supplementation (2 × 70 mL of beetroot juice ∼12.9 mmol NO3-; Beet It, James White Drinks, Ipswich, UK) or placebo (2 × 70 mL of water with beetroot powder with negligible nitrate content).
Study NCT05842603 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiac Lifestyle Program
Description: 12-week, tailored nutrition and physical activity program comprised of virtual and in-person classes.
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV Infusion
Study NCT06475248 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Technique
Description: For the technique performed in the control group, the researcher will come into contact with the volunteers' chests. This contact will be maintained for the same period of time as the experimental group (6 minutes).
Study NCT06475248 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching technique
Description: Stretching technique for the upper trapezius and sternocleidomastoid: the volunteer will be in supine position on the couch, the researcher will perform the technique from the contralateral side of the muscle to be treated, the hand will contact the ipsilateral shoulder to stabilize, meanwhile, with the other hand, contact the upper trapezius and perform a rhythmic pull in contralateral rotation. This technique is performed bilaterally.
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: IV infusion
Study NCT06162221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RMC-9805
Description: Oral Tablet
Study NCT05705258 — intervention group
Intervention type: DRUG
Intervention: Aflibercept (Eylea, BAY86-5321)
Description: Treatment with Intravitreal (IVT)-AFL must be made by the treating ophthalmologist